Phendimetrazine (Bontril) is classified as Schedule III.

Prepare for the Montana MPJE. Study with flashcards and multiple-choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Phendimetrazine (Bontril) is classified as Schedule III.

Explanation:
Understanding how the DEA classifies controlled substances helps explain this. Substances are placed in schedules based on medical use, potential for abuse, and likelihood of physical or psychological dependence. Phendimetrazine has an accepted medical use as an appetite suppressant, but its abuse and dependence potential is higher than Schedule IV drugs and lower than Schedule II drugs. That intermediate risk profile is why it’s classified as Schedule III. It’s not unscheduled, and it’s not a Schedule II or IV because those categories reflect more extreme levels of abuse potential.

Understanding how the DEA classifies controlled substances helps explain this. Substances are placed in schedules based on medical use, potential for abuse, and likelihood of physical or psychological dependence. Phendimetrazine has an accepted medical use as an appetite suppressant, but its abuse and dependence potential is higher than Schedule IV drugs and lower than Schedule II drugs. That intermediate risk profile is why it’s classified as Schedule III. It’s not unscheduled, and it’s not a Schedule II or IV because those categories reflect more extreme levels of abuse potential.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy